A research filter, not a predictor — not financial advice. Grades rank growth stocks on evidence-based quality signals from end-of-day data; they are not buy/sell calls or price forecasts. Always do your own research.
GT Biopharma, Inc. GTBP
Weak (early) broader-coverage candidate · GT Biopharma, Inc. is a biopharmaceutical company in the clinical development phase, dedicated to discovering and bringing to market novel immuno-oncology treatments. Their innovat
On FrontierLab's discovery record since 2026-09-04 (4 weeks ago) — when this name first surfaced. (distinct from the snapshot date below)
Auto-graded broader coverage — sourced by an automated screen and graded on default bands, not the sector-calibrated bands the curated screener uses. A "Weak (early)" here is NOT the same bar as a curated grade; these are auto-screened candidates for your own research, shown as of their surface date (2026-09-08), not the curated Frontier signal.
⚡ Surfaced on a price move — momentum is where to look, not a buy signal. The move that surfaced this name does not make it a good entry.
Key quality signals
| Revenue growth (YoY) | — |
|---|---|
| Gross margin | — |
| Gross profits / assets | 0 |
| Rule of 40 | — |
| Net margin | — |
| Cash runway (months) | 4.1 |
| PEG | — |
| Price / sales | — |
Quality checklist
- ✗ Capital efficiency
- ✗ Share dilution — 1300.6%
Fundamentals — snapshot as of 2026-09-08
| Stage | Early |
|---|---|
| Share issuance (YoY) | 1300.6% · heavy issuance |
| Moat | — |
| TAM | — |
| P/E (trailing) | — |
| EPS (trailing) | $-4.16 |
| Burn multiple | — |
| Gross-margin trend (pts) | — |
| Cash / assets | 0.86 |
| Net debt / EBITDA | — |
| Statements as of | Q2 FY2026 · filed 2026-08-14 |
Momentum context — a snapshot from 2026-09-08, not current
| Price at surface | $6.03 (as of 2026-09-08) |
|---|---|
| 52-week range | $0.2221 – $34.25 |
| % off 52-wk high | -82.4% |
| RSI (14) | 30 |
| Relative volume | 2.4× |
Risk flags
← All broader-coverage names · Curated names → · Open the interactive screener →
Data as of 2026-09-08 (end-of-day). How grades are computed →